A Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501

Clinical trial NCT01549054 · COMPLETED

Trial details

NCT number: NCT01549054
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Thrombocytopenic Purpura

Start date: 2012-01-01
Primary completion: 2012-06-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.